Silica nanocapsules have attracted tremendous interest for encapsulation, protection and controlled release of various cargoes due to their unique hierarchical core-shell structure. However, it remains challenging to synthesize silica nanocapsules having high cargo-loading capacity and cargo-protection capability without compromising process simplicity and biocompatibility properties. Here, we synthesized oil-core silica-shell nanocapsules under environmentally friendly conditions by a novel emulsion and biomimetic dual-templating approach using a dual-functional protein, in lieu of petrochemical surfactants, thus avoiding the necessities for the removal of toxic components. A light-and pH-sensitive compound can be facilely encapsulated in the silica nanocapsules with the encapsulation efficiency of nearly 100%. Release of the encapsulated active from the nanocapsules was not shown an indication of undesired burst release. Instead, the release can be tuned by controlling the silica-shell thicknesses i.e., 40 and 77 nm from which the cargo released at 42.0 and 31.3% of the initial amount after 32 days, respectively. The release kinetics were fitted well to Higuchi model, enabling the possibility of the prediction of release kinetics as a function of shell thickness thus achieving design-for-purpose silica nanocapsules. Furthermore, the nanocapsules showed excellent alkaline-and sunlight-shielding protective efficacies which resulted in significantly prolonged half-life of the sensitive cargo. Our biomimetic silica nanocapsules provide a nanocarrier platform for applications that demand process scalability, sustainability and biocompatibility coupled with unique cargo-protection and controlled-release properties.
INTRODUCTION
In the past decades, a wide variety of nanomaterials has been developed as nanocarriers for encapsulation and release of various active ingredients for applications ranging from pharmaceutical and nutraceutical to agricultural and personal care. [1] [2] [3] Ideally, these nanomaterials should facilitate high loading capacity with controllable release and protection as many actives (e.g., therapeutics, 4 imaging agents, 5 nutrients, 6 agrochemicals, 7 and fragrance 8 ) are sensitive to local environments (e.g., heat, light, pH) and hence prone to undergo degradation. However, it remains challenging to encapsulate and deliver these active agents while maintaining their stabilities, hence functionalities, for specific applications. A lot of efforts has been dedicated to develop new strategies for the design and synthesis of various types of nanomaterials based on polymer, [9] [10] [11] lipid, [12] [13] [14] and inorganic [15] [16] [17] materials to protect and release such actives. Among them, inorganic silica nanomaterials have attracted significant interest due to their robust properties such as being mechanically strong, chemically stable, and relatively biocompatible. [18] [19] Inorganic silica nanocapsules are promising as nanocarriers owing to their unique core-shell architecture. 20 The core retains the actives and provides high loading capacity, while the shell protects the actives from the surrounding environment and acts as a diffusion barrier that controls release of the encapsulated actives. Templating methods have been widely utilized to synthesize silica nanocapsules using either hard (i.e., solid nanoparticles [21] [22] ) or soft (i.e., emulsion droplets [23] [24] and gas bubbles [25] [26] templates. These approaches variously involve the use of chemical surfactants, organic solvents and template materials that are toxic, thus requiring tedious monitoring procedures for ensuring their complete removal down to the level that can be regarded as environmentally safe. Additionally, extreme pH and elevated temperature typically used during silica formation are obviously not suitable when sensitive active agents aforementioned are encapsulated prior to the silica formation. Although an active can be post-loaded into the prepared silica nanocapsules, these strategies are time consuming and often result in low loading capacity and initial burst release due to the adsorbed active present on the nanocapsules' surfaces. New methods for synthesizing silica nanocapsules for the encapsulation of sensitive materials using components and processes that are biocompatible and environmentally safe are urgently needed.
Inspired by Nature, biomimetic templating methods have emerged as relatively new approaches to synthesize silica-based nanocarriers owing to the abilities of mineralizing biomolecules to recognize, interact with, and direct the nucleation and growth of silica under physiological conditions. [27] [28] [29] [30] [31] For example, Jakhmola et al. synthesized oil-core silica-shell nanocapsules thereby using a layer-by-layer assembly method in which oppositely charged biomolecules were alternately deposited on a nanoemulsion template followed by silica mineralization. 32 Erni et al.
reported the synthesis of silica capsules having a diameter at a scale of hundreds of micrometers by silicification of cross-linked coacervate of gelatin and Acacia gum around oil droplets. 33 Recently, we developed a novel emulsion and biomimetic dual-templating technology to synthesize silica nanocapsules. 24 This technology is based on the rational design of dual-functional peptides 24 or proteins 34 in lieu of chemical surfactants. The designed biomolecules are capable of stabilizing pharmaceutically-grade oil droplets (emulsification functionality) and concurrently inducing the formation silica shells (biomimetic-silicification functionality) at near-neutral pH and room temperature without the use of toxic organic solvents, 24, 34 thus eliminating adverse environmental effects. [35] [36] In addition, encapsulation of an active is facile through its direct dissolution in the oil core prior to the silica-shell formation, enabling high encapsulation efficiency and avoiding initial burst release. More importantly, the bifunctional proteins can be produced via a simple and cheap engineered bioprocess, 37 thus paving a pathway for large-scale economic production where cost is a competitive driver. While the bioenabled synthesis of silica nanocapsules has been described, release kinetics of an encapsulated active from silica nanocapsules as well as their capability of protecting the active under various conditions have not been studied
In this work, the performances of silica nanocapsules to encapsulate, protect and release a sensitive cargo were systematically investigated to better understand their stability, release mechanisms and kinetics under different conditions. Fipronil, that is sensitive to light and pH, was used as a model active ingredient. Fipronil is an agrochemical that has been applied, for instance, in rice paddy fields 38 which essentially expose it to both sunlight and soil acidity/alkalinity. Silica nanocapsules with two shell thicknesses were synthesized and used as nanocarriers for fipronil to study its encapsulation and sustained release, as well as its protective efficacies against simulated sunlight and different pHs. This study will provide a rational basis for designing and synthesizing novel and rational nanocarriers with desirable properties for controlled release. 
EXPERIMENTAL SECTION

Materials
Dynamic light scattering (DLS).
Size distribution and zeta potential of nanoemulsions and silica nanocapsules were determined by DLS using Malvern Zetasizer Nano ZS (Malvern Instrument Ltd., Malvern, UK) at a scattering angle of 173° and a temperature of 25 °C. The samples were diluted prior to the measurements to avoid multiple scattering effects.
Transmission electron microscopy (TEM).
Morphology of silica nanocapsules was observed by TEM using a JEOL 1010 (JEOL, Tokyo, Japan) operated at 100 kV. The silica nanocapsule suspensions (2 μL) were deposited onto Formvar-coated copper grids (ProSciTech, Townsville, Australia). The size and shell thickness of the silica nanocapsules were analyzed using iTEM software (Version 3.2, Soft Imaging System GmbH, Münster, Germany). Encapsulation Efficiency. To measure the efficiency of fipronil encapsulation, acetonitrile was added to the suspensions of silica nanocapsules to completely extract fipronil from the oil as fipronil has high solubility in acetonitrile. 24 Then the mixture was centrifuged to obtain the supernatant in which the concentration of fipronil was measured using RP-HPLC as described above. The encapsulation efficiency (%EE) was calculated as the ratio of the encapsulated amount of fipronil compared to the initial amount of fipronil dissolved in Miglyol 812 oil:
where Cs (mg/mL) and Vs (mg/mL) are the concentration of fipronil in the supernatant and the volume of the supernatant, respectively, and C0 (mg/mL) and V0 (mg/mL) are the initial concentration of fipronil in Miglyol 812 oil and the volume of Miglyol 812 oil, respectively.
In Vitro Release in Water. The release profiles of fipronil from nanoemulsions and silica nanocapsules having two different silica-shell thicknesses were investigated in water. The were taken and replaced with fresh water. Samples were then analyzed using RP-HPLC to determine the concentration of fipronil as described above.
In Vitro Release at different pHs. The release profiles of fipronil from nanoemulsions and silica nanocapsules having thickest shell thickness were studied in water and in solutions of pH 2 and pH 11. Solutions of pH 2 and pH 11 were obtained by mixing HCl or NaOH with water, respectively. The nanoemulsions and the silica nanocapsule suspensions (100 µL) were mixed with 10 mL water and pH 2-and pH 11-solutions by shaking at room temperature for up to 32 d. At different time intervals, aliquots (500 µL) of the suspensions were taken and replaced with fresh water and pH 2-and pH 11-solutions. All samples were neutralized to pH 7 by adding 50 µL of NaOH (pH 13) or HCl (pH 2) solution prior to fipronil analysis using RP-HPLC. For the neutralized silica nanocapsules, fipronil concentrations were examined both in the external solution and in the inside silica nanocapsules. To determine the fipronil concentration in the external solution, the silica nanocapsule suspension was centrifuged to obtain the supernatant which was then directly analyzed by using RP-HPLC. To determine the fipronil concentration inside the silica nanocapsules, the precipitates obtained after centrifugation were mixed with acetonitrile and then sonicated using ultrasonicator for eight 30 s bursts at 40 W and interspersed in an ice bath for 60 s, followed by shaking for 48 h to completely extract fipronil to the bulk solutions. Then the mixtures were centrifuged to obtain the supernatants which were subjected to RP-HPLC analysis. After 32 d, the silica nanocapsules with different pH treatment were visualized by using TEM. were dispersed in 10 mL water under different radiation conditions at a room temperature for up to 72 h. At different time intervals, aliquots (500 µL) of the suspensions were taken, replaced with fresh water, and then centrifuged to obtain supernatants (100 µL) which were subjected to fipronil analysis using RP-HPLC. On the other hand, the precipitates were resuspended and mixed with acetonitrile (500 µL) then sonicated using a Branson Sonifier 450 ultrasonicator for eight 30 s bursts at 40 W and interspersed in an ice bath for 60 s, followed by shaking for 48 h. Then samples were centrifuged to obtain the supernatants which were analyzed by using RP-HPLC. After 72 h, the silica nanocapsules with different radiation treatment were visualized by using TEM. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 hydrophobic residues of the protein to face and anchor to the oil droplets, while their hydrophilic residues projected toward the aqueous phase providing steric and electrostatic stabilization. After adding the silica precursor tetraethoxysilane (TEOS) to the nanoemulsions, a silica shell encasing the nanoemulsion core was formed through a biosilicification process at pH 7.5 and room temperature without using any organic solvents. The biosilicification-active module, which is densely packed with cationic amino acid residues as well as polar amino acid residues, oriented within the subinterfacial region between nanoemulsion and bulk solution induce the hydrolysis of TEOS and the polycondensation of the hydrolyzed TEOS at the oil-water interfaces through nucleophilic attack, H-bonding and electrostatic interaction mechanisms, 24 hence ultimately forming silica shell encapsulating the oil core. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 interface under near-neutral pH and room temperature without the use of toxic organic solvents.
RESULTS AND DISCUSSION
Synthesis and
The cargo (fipronil) is encapsulated by dissolving it in the oil prior to emulsification. This is in contrast with other silica nanoparticles which have significant amount of initial burst release.
41-42
The release kinetics of fipronil were fitted to different models. It was found that the release of fipronil from NEs, SNCs-40 and SNCs-77 can be well described by the Higuchi model ( Figure 3 ):
where Q is the accumulated release of fipronil (%), kH is the Higuchi constant, and t 1/2 is the square root of time. Good linear correlations (regression from the Higuchi model; R 2 > 0.95) can be observed (Figure 3) , suggesting that the release of our silica nanocapsules are controlled by diffusion. Based on the Higuchi model, the complete release of fipronil can be achieved at 69, 158
and 286 d for the NEs, SNCs-40 and SNCs-77, respectively, demonstrating a significant role of the silica shell in slowing down the release consistent with the experimental results described above. We have observed a linear relationship between the shell thickness and the Higuchi constant based on the three shell thicknesses (0, 40, and 77 nm) ( Figure S1 ), which may enable us to predict the release profiles based on the shell thickness thus achieving purposely designed silica One-way ANOVA was used to determine statistical significance, with P value <0.05 denoted as *.Effect of pH on the Fipronil Release. The effects of pH on the release profiles of fipronil from the silica nanocapsules having thickest shell thickness (SNCs-77) were investigated in a 32-d period. Figure 4 shows the release of fipronil from SNCs-77 in water and in solutions of pH 2 and pH 11. As fipronil can be rapidly hydrolyzed at pH 11, the concentration of fipronil inside the nanocapsules was measured by first disrupting the core-shell structure of nanocapsules and then fipronil released out of the nanocapsules can be neutralized prior to analysis using RP-HPLC. The
SNCs-77 demonstrated a sustained release of fipronil at all pH conditions. The fipronil release was much faster at pH 11 than those at pH 2 and in water, indicating that the silica shell was less stable at pH 11. At the end of the 32-d period, the accumulated fipronil release in water and in solutions of pH 2 and pH 11 were 35.7 ± 3.9, 56.1 ± 2.5 and 84.8 ± 2.9%, respectively. After 32-d release experiments, the silica nanocapsules were observed by using TEM ( Figure 5 ). The silica nanocapsules incubated at pH 2 showed a unique hedgehog-like morphology ( Figure 5A ), and the shell thickness decreased significantly from 77 ± 2 to 26 ± 9 nm, indicating the gradual degradation of the silica shell. The silica nanocapsules incubated in water remained slightly intact with a rough topology on their surfaces ( Figure 5B ), and the shell thickness decreased slightly from 77 ± 2 to 67 ± 6 nm. At pH 11, most silica nanocapsules disintegrated into small silica nanoparticles with a diameter ranging from 1 to 20 nm ( Figure 5C ). All silica nanocapsules incubated at the conditions aforementioned demonstrated degradability dependent on solution pH. This is because amorphous silica can undergo hydrolysis to soluble silanols (≡Si-OH) by breaking the siloxane bonds (≡Si-O-Si≡) which is further catalyzed by either acid or alkaline. 43 Moreover, the TEM images of the silica nanocapsules ( Figure 5 ) corresponded well with the release profiles at three different pHs (Figure 4) , as the more stable the shell, the slower was the release. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 2 and SNCs-77-pH 2) and in water (NEs-Water and SNCs-77-Water), indicating its stability under these conditions. However, for the nanoemulsions incubated at pH 11 (NEs-pH 11), the Ct/Ct0 decreased significantly from 100% to 80.2 ± 3.4% in only 3 h, and then remained declining until no fipronil could be detected at day 4, indicating a complete hydrolysis of fipronil. The Ct/C0 vs time follows a pseudo-first-order reaction (half-life = 0.83 d):
where r is the hydrolysis rate, k is the second-order constant, Ct is the total concentration of the remaining fipronil in the system, and COH -is the concentration of hydroxide ion. The COH -is considered as a constant in this study, therefore the hydrolysis rate becomes:
where k' is the pseudo-first order constant, making the hydrolysis process a pseudo-first-order 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Protective Efficacy of Silica Shell against Sunlight. Driven by the fact that many active ingredients, such as ibuprofen, 45 darbepoetin-α, 46 vinclozolin, 47 and hydramethylnon, 48 are light sensitive and thus require a great care during long-term storage, we also investigated the efficacies of silica nanocapsules for protection of encapsulated actives against light. Fipronil encapsulated in silica nanocapsules having 77 nm-shell was used in this study as it is also sensitive to light hence prone to undergo photolysis. 44 A solar simulator (1000 W/m 2 , equivalent to 1 sun intensity) was used to mimic natural sunlight. Figure 7 shows the variation of Ct/C0 (i.e., the ratio of the total concentration of fipronil inside and outside the nanoemulsions or nanocapsules to its initial concentration) under light exposure and dark condition over a 72-h period. The Ct/C0 (Figure 7) represents the degradation rate of fipronil under the light. The total concentrations of fipronil 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 light (NEs-L) decreased dramatically to 68.9 ± 4.1% at 1.13 h, and it was completely degraded at 9 h. The degradation of fipronil followed a first-order reaction model with a degradation half-life of 2.27 h. In contrast, the concentrations of fipronil in the silica nanocapsules under light exposure The concentrations of fipronil inside the silica nanocapsules were calculated and compared under light exposure and dark condition to determine whether fipronil inside the nanocapsules remained intact. Figure 8A shows the variation of Ci/C0 (i.e., the ratio of the fipronil concentration inside the silica nanocapsules to its initial concentration) under simulated light and dark conditions and the protection efficacy was around 70.6% (=61.5/87.1). Figure 8B shows the variation of the Ce/C0 (i.e., the ratio of the fipronil concentration in the external buffer solution to the initial concentration) under both dark and light conditions over a 72-h period. It is clear that fipronil was released gradually from the silica nanocapsules that incubated under dark condition (Ex-SNCs-77-D). As expected, no fipronil can be detected for those silica nanocapsules incubated under light condition (Ex-SNCs-77-L). This is because once fipronil released from the silica nanocapsules it exposed to the light and underwent rapid photo-degradation. 
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Notes
The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A, alanine; D, aspartic acid; DLS, dynamic light scattering; E, glutamic acid; EE, encapsulation efficiency; G, glycine; H, histidine; HEPES, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid; K, lysine; L, leucine; M, methionine; MW, molecular weight; NEs, nanoemulsions; P, proline; Q, glutamine; R, arginine; RP-HPLC, reversed-phase high-performance liquid chromatography; S, serine; SNCs, silica nanocapsules; TEM, transmission electron microscopy; TEOS, tetraethoxysilane; TFA, trifluoroacetic acid; V, valine; Y, tyrosine; Ð, dispersity. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
